Pure Global

NuCLEUS Percutaneous Transluminal Valvuloplasty (PTV) Catheter - Catheter, valvuloplasty, balloon dilatation

Access comprehensive regulatory information for NuCLEUS Percutaneous Transluminal Valvuloplasty (PTV) Catheter - Catheter, valvuloplasty, balloon dilatation in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by Device Technologies Australia Pty Ltd, manufactured by Numed Canada Inc in Canada. The device registration started on December 15, 2008.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.

Free Database
Powered by Pure Global AI
TGA ARTG Official Data
Class III
Class III
NuCLEUS Percutaneous Transluminal Valvuloplasty (PTV) Catheter - Catheter, valvuloplasty, balloon dilatation
Australia TGA ARTG Registered Device
Good Name: Device Technologies Australia Pty Ltd - NuCLEUS Percutaneous Transluminal Valvuloplasty (PTV) Catheter - Catheter, valvuloplasty, balloon dilatation
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Intended Purpose

A flexible, balloon-tipped catheter recomended for use in Percutaneous Transluminal Valvuloplasty (PTV) for mitral and aortic position and centered angioplasty applications.

Device Classification
Risk Class
Class III
Product Type
Single Device Product
ARTG Category
General
Registration Information
Start Date
December 15, 2008
Effective Date
December 15, 2008
Manufacturer
Country
Canada
Address
45 Second Street, West Cornwall, Ontario, K6J 1G3